Monday, December 23, 2024
- Advertisement -spot_img

TAG

Gilead

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

MEXICO CITY (AP) — It’s been called the closest the world has ever come to a vaccine against the AIDS...

This ‘forgotten child’ is one of the best biotech plays: Analyst

Jefferies biotech analyst Michael Yee joins Market Domination to lay out his bull case on Gilead (GILD) and how investors should consider their biotech...

Latest news

- Advertisement -spot_img